SANUWAVE Health Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $39.7M
- Price
- $4.61
- % Change (Daily % change from the live per-ticker quote feed.)
- -5.92%
- Volume
- 67.1K
About
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
Quick stats
Shares outstanding8.6M
Computed float5.3M
Float / shares61.5%
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001417663
Websitehttps://sanuwave.com
AI Summary
AI-generated1/12
standardbearishearnings
Sanuwave Announces Q2 FY2026 Financial Results
Sanuwave reported Q2 revenue of $9.7 million, down 3% year-over-year, with net income swinging to a loss of $0.7 million compared to a profit in the prior year.
The company cited a challenging market environment, noting a decline in Ultramist system sales to 82 units and the negative impact of CMS reimbursement changes and a secondary market for used equipment.
Due to ongoing regulatory uncertainty, Sanuwave withdrew its full-year 2026 guidance and does not expect to issue new outlooks until the CMS final rule is released in the fourth quarter.
Red flags
- Full-year 2026 guidance withdrawn due to regulatory uncertainty
- System sales declined to 82 units from 116 in Q2 2025
- Net loss of $0.7 million vs net income of $0.6 million in prior year
- Emergence of secondary market for used systems cannibalizing new sales